Patents


Nature Biotechnology 26, 55 - 56 (2008)
doi:10.1038/nbt0108-55

Reach-through claims for drug target patents: Rx for pharmaceutical policy

Robert A Bohrer1


Recognizing the value of the discovery and validation of new pharmaceutical targets would be a major step forward for pharmaceutical policy.

Top
  1. Robert A. Bohrer is at California Western School of Law, 225 Cedar Street, San Diego, California 92101, USA. e-mail: rab@cwsl.edu



Extra navigation

Search PubMed for

Open Innovation Challenges

naturejobs

ADVERTISEMENT